TiNO-Coated Stents Noninferior at 12 Months, Superior at 18 Months to EES in Preventing MACE in ACS Patients
Cobalt-chromium-based titanium-nitride-oxide (TiNO)-coated stents were non-inferior to platinum-chromium-based biodegradable-polymer everolimus-eluting stents (EES) at 12 months and superior at 18 months with regard to major adverse cardiovascular events (MACE) in patients with acute coronary syndromes (ACS), according to study results released Monday.